We are live on ! Find out more
CW

Cabot-Wellington Portfolio holdings

AUM $380M
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
-0.39%
1 Year Est. Return
+21.78%
3 Year Est. Return
+64.98%
5 Year Est. Return
+59.32%
10 Year Est. Return
+170.75%
AUM
$269M
AUM Growth
-$222K
Cap. Flow
+$2.83M
Cap. Flow %
1.05%
Top 10 Hldgs %
57.24%
Holding
45
New
1
Increased
9
Reduced
19
Closed
3

Sector Composition

Rank Sector Weight
1 Energy 29.32%
2 Healthcare 23.02%
3 Technology 14.01%
4 Materials 8.66%
5 Financials 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTRA
1
DELISTED
Coterra Energy
CTRA
$29.1M 10.83%
984,158
-11,150
-1% -$351K
CBT icon
2
Cabot Corp
CBT
$4.54B
$18.1M 6.74%
413,323
-1,505
-0.4% -$68K
GILD icon
3
Gilead Sciences
GILD
$162B
$15.1M 5.62%
160,437
-14,225
-8% -$1.47M
GLD icon
4
SPDR Gold Trust
GLD
$131B
$14.9M 5.55%
131,555
+32
+0% +$3.69K
CVS icon
5
CVS Health
CVS
$134B
$13.5M 5.03%
140,686
-1,555
-1% -$137K
EPD icon
6
Enterprise Products Partners
EPD
$81.9B
$13.2M 4.91%
366,123
-3,872
-1% -$143K
QCOM icon
7
Qualcomm
QCOM
$157B
$13M 4.83%
174,925
+1,575
+0.9% +$115K
WIP icon
8
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$471M
$12.8M 4.76%
225,120
-590
-0.3% -$34.5K
SYK icon
9
Stryker
SYK
$125B
$12.2M 4.54%
129,550
-750
-0.6% -$66.5K
EMC
10
DELISTED
EMC CORPORATION
EMC
$11.9M 4.43%
400,603
-1,850
-0.5% -$53.8K
ABBV icon
11
AbbVie
ABBV
$446B
$11.9M 4.42%
181,636
-2,075
-1% -$131K
MMP
12
DELISTED
Magellan Midstream Partners, L.P.
MMP
$11.6M 4.3%
140,160
-2,050
-1% -$167K
SLB icon
13
SLB Ltd
SLB
$73.5B
$11.2M 4.15%
130,780
+20,190
+18% +$1.86M
ABT icon
14
Abbott
ABT
$183B
$8.21M 3.05%
182,251
RTX icon
15
RTX Corp
RTX
$289B
$7.45M 2.77%
102,913
STT icon
16
State Street
STT
$50.6B
$7.23M 2.69%
92,130
-625
-0.7% -$46.9K
ORCL icon
17
Oracle
ORCL
$372B
$6.84M 2.54%
152,195
-1,775
-1% -$72.2K
CB
18
DELISTED
CHUBB CORPORATION
CB
$6.75M 2.51%
65,245
+50
+0.1% +$4.98K
GOOG icon
19
Alphabet (Google) Class C
GOOG
$4.34T
$6.33M 2.35%
239,476
+47,129
+25% +$1.26M
XOM icon
20
ExxonMobil
XOM
$641B
$5.58M 2.07%
60,323
-50
-0.1% -$4.66K
MON
21
DELISTED
Monsanto Co
MON
$5.19M 1.93%
43,415
JPM icon
22
JPMorgan Chase
JPM
$938B
$4.75M 1.77%
75,912
+600
+0.8% +$36.1K
AAPL icon
23
Apple
AAPL
$4.44T
$3.97M 1.48%
143,984
NVGS icon
24
Navigator Holdings
NVGS
$1.37B
$3.72M 1.38%
+176,450
New +$3.87M
COP icon
25
ConocoPhillips
COP
$146B
$2.69M 1%
38,906

Similar funds

Cabot-Wellington's Q4 2014 Portfolio in Review

As of Q4 2014, Cabot-Wellington held 45 positions worth $269M, down 0.08% from $269M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Cabot-Wellington's Q4 2014 filing shows 1 new, 9 increased, 19 reduced and 3 closed positions. Its largest new stake was Navigator Holdings: 176,450 shares worth $3.72M. The largest sale was Gilead Sciences, an estimated $1.47M.

By sector, the portfolio is most concentrated in Energy at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Technology.

  • Cabot-Wellington's largest Q4 2014 buy was Navigator Holdings: 176,450 shares worth $3.72M.
  • Cabot-Wellington added most to SLB Ltd in Q4 2014, an estimated $1.86M increase.
  • Cabot-Wellington's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $1.47M.
  • Cabot-Wellington fully exited Vanguard FTSE Emerging Markets ETF in Q4 2014, selling an estimated $463K.
  • Cabot-Wellington's ten largest holdings make up 57% of its $269M portfolio in Q4 2014.
  • Cabot-Wellington opened 1 new position and closed 3 in Q4 2014.
  • Cabot-Wellington's portfolio value fell 0.08% quarter-over-quarter to $269M.

Based on Cabot-Wellington's 13F filing for Q4 2014, filed 11 Feb 2015.